Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 13, 2020 7:00 AM 3 min read

CBD Life Sciences Inc. Announces Its New Product "CBD Pre-Rolls"

by ACCESS Newswire
Follow

SCOTTSDALE, AZ / ACCESSWIRE / May 13, 2020 / CBD Life Sciences Inc. (OTC:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is pleased to announce that our new product "CBD Pre-Rolls "arrived to our Facility and is readily available to be purchased. The product consists of 1 gram of CBD Hemp Flower that contains less than 0.3% of THC. The product is meant to be smoked so users can instantly feel the effects of CBD such as pain relief, anxiety relief, stress relief and more! The product is retailing for $14.99 and consumers can place their order today on our website www.lbcbioscienceinc.com.

The CBD "(cannabidiol) market is rapidly growing and has shown promising indication for the health & wellness industry. Widespread use is increasing throughout the public. Follow our social media accounts at www.instagram.com/lbcbioscience www.linkedin.com/company/lbcbioscienceinc & www.twitter.com/lbcbioscience for updating information.

Lisa Nelson, President/CEO of CBD Life Sciences, Inc. commented "We are pleased to announce that our new product (CBD Pre-Rolls) are available for consumers to purchase. Users can instantly feel the benefits of CBD while smoking our CBD Pre-Roll. I am looking forward to our customers trying out our latest product and giving us feedback."

Lisa Nelson continued "CBD Pre-Rolls are the hottest Cannabidiol products on the market and we strive to bring our consumers the highest quality of CBD." Lisa ended with "The Company will continue to update the public about new product releases, trades shows, events and any updated information regarding LBC Bioscience Inc."

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Ten Associates LLC

Contact: Thomas E. Nelson

Telephone: (480) 326-8577

Email: [email protected]

Website: www.tenassociatesllc.com

Forward-Looking Statements

Safe Harbor Statement

SOURCE: CBD Life Sciences Inc.



View source version on accesswire.com:

https://www.accesswire.com/589647/CBD-Life-Sciences-Inc-Announces-Its-New-Product-CBD-Pre-Rolls

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPress Releases
CBDL Logo
CBDLCBD Life Sciences Inc
$0.00015-25.0%
Overview
YCBD Logo
YCBDcbdMD Inc
Not Available-%

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.

CBDL Logo
CBDLCBD Life Sciences Inc
$0.00015-25.0%
Overview
YCBD Logo
YCBDcbdMD Inc
Not Available-%
Comments
Loading...